Explore more about: Brain Disorders

The novel approach better mimics the tumor environment in patients. Made with extracellular matrix (ECM) from pig brains and seeded with tumors from patients, the system is revealing tumor/ECM interactions that aid tumor growth, providing potential targets for new therapies.

Researchers have developed 3-dimensional human tissue culture models of pediatric and adult brain cancers in a brain-mimicking microenvironment, that includes brain-derived extracellular matrix (ECM) -- the complex network of proteins and amino acids with bound sugars that not only provides support for surrounding neural tissue, but also helps to guide cell growth and development. The development represents a significant advancement for the study of brain tumor biology and pharmacological response.

A metamaterial made of plastic and copper may be able to enhance the quality (signal-to-noise ratio) of magnetic resonance imaging (MRI) by four times and speed up scan times by 14 times.

Researchers demonstrate critical improvements to functional Near Infrared Spectroscopy (fNIRS)-based optical imaging in the brain.

Using a mouse model of stuttering, scientists report that a loss of cells called astrocytes in the brain is associated with stuttering.

Researchers have taken a key step forward in developing a new, possibly safer contrast agent for use in MRI exams.

Brain function can be tracked in real-time using a new MRI method that has the potential to shed light on altered neuronal activity in brain diseases.

NIBIB-funded researchers use passive cavitation imaging, an ultrasound imaging technique, to create an image and estimate the amount of drug that crossed the blood-brain barrier to reach a specific location in the brain.

Researchers funded by NIBIB have designed neuron-like probes that can be implanted and remain viable for long-term use to study and treat the brain.

Researchers are one step closer to delivering precise amounts of medication to exact location.